The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated
The DOI matches its OpenAlex record.
Abstract
The one or more molecular mechanisms that determine the obligatory sequence of resorption followed by formation during bone remodeling is unclear. RANK ligand (RANK-L) is an essential requirement for osteoclastogenesis, and its activity is neutralized by binding to the soluble decoy receptor, osteoprotegerin (OPG). Because both molecules are produced by osteoblast lineage cells, we studied their developmental regulation in a conditionally immortalized human marrow stromal (hMS[2–15]) cell line. These cells can simulate the complete developmental sequence from undifferentiated precursor(s) to cells with the complete osteoblast phenotype that are capable of forming mineralized nodules. During osteoblast differentiation, RANK-L messenger RNA levels decreased by 5-fold, whereas OPG messenger RNA levels increased by 7-fold, resulting in a 35-fold change in the RANK-L/OPG ratio. OPG protein also increased by 6-fold. Mouse bone marrow cells generated osteoclast-like cells in coculture with undifferentiated hMS(2–15) cells, but did not when cocultured with hMS(2–15) cells in varying stages of differentiation, unless an excess of RANK-L was added. Thus, undifferentiated marrow stromal cells with a high RANK-L/OPG ratio can initiate and support osteoclastogenesis, but after differentiation to the mature osteoblast phenotype, they cannot. We speculate that the developmental regulation of OPG and RANK-L production by stromal/osteoblast cells contributes to the coordinated sequence of osteoclast and osteoblast differentiation during the bone remodeling cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- Parfitt, 1994, Osteonal and hemi-osteonal remodeling: the spiral and temporal framework for signal traffic in adult human bone., J Cell Biochem, 55, 273, 10.1002/jcb.240550303 · DOI · Paper page
- Suda, 1992, Modulation of osteoclast differentiation., Endocr Rev, 13, 66
- Roodman, 1994, Advances in bone biology: the osteoclast., Endocr Rev, 17, 308
- Howard, 1981, Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism., Proc Natl Acad Sci USA, 78, 3204, 10.1073/pnas.78.5.3204 · DOI · Paper page
- Bonewald, 1990, Role of transforming growth factor-β in bone remodeling., Clin Orthop, 250, 261, 10.1097/00003086-199001000-00036 · DOI · Paper page
- Takahashi, 1988, Osteoblastic cells are involved in osteoclast formation., Endocrinology, 123, 2600, 10.1210/endo-123-5-2600 · DOI · Paper page
- Jilka, 1996, Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence., J Clin Invest, 97, 1732, 10.1172/JCI118600 · DOI · Paper page
- Ducy, 1999, A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development., Genes Dev, 13, 1025, 10.1101/gad.13.8.1025 · DOI · Paper page
- Ducy, 1997, Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation., Cell, 89, 747, 10.1016/S0092-8674(00)80257-3 · DOI · Paper page
- Komori, 1997, Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts., Cell, 89, 755, 10.1016/S0092-8674(00)80258-5 · DOI · Paper page
- Otto, 1997, Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development., Cell, 89, 765, 10.1016/S0092-8674(00)80259-7 · DOI · Paper page
- Weinstein, 1997, The effect of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage., Endocrinology, 138, 4013, 10.1210/endo.138.9.5359 · DOI · Paper page
- Lacey, 1998, Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation., Cell, 93, 165, 10.1016/S0092-8674(00)81569-X · DOI · Paper page
- Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density., Cell, 89, 309, 10.1016/S0092-8674(00)80209-3 · DOI · Paper page
- Yasuda, 1998, Identity of osteoclastogenesis factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro., Endocrinology, 39, 1329, 10.1210/endo.139.3.5837 · DOI · Paper page
- Tan, 1997, Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic cells., Gene, 204, 35, 10.1016/S0378-1119(97)00509-X · DOI · Paper page
- Bucay, 1998, Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification., Gene Dev, 12, 1260, 10.1101/gad.12.9.1260 · DOI · Paper page
- Mizuno, 1998, Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin., Biochem Biophys Res Commun, 247, 610, 10.1006/bbrc.1998.8697 · DOI · Paper page
- Burgess, 1999, The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts., J Cell Biol, 145, 527, 10.1083/jcb.145.3.527 · DOI · Paper page
- Nakagawa, 1998, RANK is the essential signaling receptor of osteoclast differentiation factor in osteoclastogenesis., Biochem Biophys Res Commun, 253, 395, 10.1006/bbrc.1998.9788 · DOI · Paper page
- Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function., Nature, 390, 175, 10.1038/36593 · DOI · Paper page
- Hsu, 1999, Tumor necrosis receptor family member RANK mediated osteoclast differentiation and activation induced by osteoprotegerin ligand., Proc Natl Acad Sci USA, 96, 3540, 10.1073/pnas.96.7.3540 · DOI · Paper page
- Quinn, 1998, A combination of osteoclast differentiation factor and macrophages-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro., Endocrinology, 139, 4424, 10.1210/endo.139.10.6331 · DOI · Paper page
- Hicok, 1998, Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma., J Bone Miner Res, 13, 205, 10.1359/jbmr.1998.13.2.205 · DOI
- Gori, 1999, Differentiation of human marrow stromal cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment and inhibits late adipocyte maturation., J Bone Miner Res, 14, 1522, 10.1359/jbmr.1999.14.9.1522 · DOI · Paper page
- Hofbauer, 1999, Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanism of glucocorticoid-induced osteoporosis., Endocrinology, 140, 4382, 10.1210/endo.140.10.7034 · DOI · Paper page
- Puzas, 1985, Bone cell phosphotyrosine phosphate: characterization and regulation by calcitropic hormones., Endocrinology, 116, 2463, 10.1210/endo-116-6-2463 · doi:10.1210/endo-116-6-2463
- Bodine, 1996, Development and characterization of a conditionally transformed adult human osteoblastic cell line., J Bone Miner Res, 11, 806, 10.1002/jbmr.5650110612 · DOI
- Lehrach, 1997, RNA molecular weight determination by gel electrophoresis under denaturating conditions, a critical reexamination., Biochem Cell, 89, 747
- Thomas, 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulosa., Proc Natl Acad Sci USA, 77, 5201, 10.1073/pnas.77.9.5201 · DOI · Paper page
- Feinberg, 1983, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity., Anal Biochem, 132, 6, 10.1016/0003-2697(83)90418-9 · DOI · Paper page
- Hofbauer, 1998, Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2 and cytokines., Biochem Biophys Res Commun, 250, 776, 10.1006/bbrc.1998.9394 · DOI · Paper page
- Cheng, 1994, Differentiation of human bone marrow osteogenic stromal cells in vitro. Induction of the osteoblast phenotype by dexamethasone., Endocrinology, 134, 277, 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
- Grigoriadis, 1988, Differentiation of muscle, fat, cartilage and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone., J Cell Biol, 106, 2139, 10.1083/jcb.106.6.2139 · DOI · Paper page
- Locklin, 1995, In vitro effects of growth factors and dexamethasone on rat marrow stromal cells., Clin Orthop, 313, 27
- Rickard, 1994, Induction of rapid osteoblast differentiation in rat bone marrow stromal cell culture by dexamethasone and BMP-2., Dev Biol, 12, 871
- Franceschi, 1992, The role of ascorbic acid in mesenchymal differentiation., Nutr Rev, 50, 65, 10.1111/j.1753-4887.1992.tb01271.x · DOI · Paper page
- Nagai, 1999, Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation., Biochem Biophys Res Commun, 257, 719, 10.1006/bbrc.1999.0524 · DOI · Paper page
- Kitazawa, 1999, Promotor structure of mouse RANKL/TRANCE/OPGL/ODF gene., Biochim Biophys Acta, 1445, 134, 10.1016/S0167-4781(99)00032-9 · DOI
- Romas, 1997, Cytokines in the pathogenesis of osteoporosis, Osteoporos Int, 7, S47, 10.1007/BF03194342 · DOI
- Adebanjo, 1998, Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption., J Cell Biol, 142, 1347, 10.1083/jcb.142.5.1347 · DOI
- Fuller, 1998, TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts., J Exp Med, 188, 997, 10.1084/jem.188.5.997 · DOI · Paper page
- Weng, 2000, The monoclonal antibodies 18d7/91f2 recognize a receptor regulatory protein on mouse bone marrow stromal cells., J Bone Miner Res, 15, 1286, 10.1359/jbmr.2000.15.7.1286 · doi:10.1359/jbmr.2000.15.7.1286
- Hughes, 1996, Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β., Nat Med, 2, 1132, 10.1038/nm1096-1132 · DOI · Paper page
Cited by
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16069 · Cited by 616
Gravallese, E. M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii84 · Cited by 328
A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone
Andersen, T. L., Sondergaard, T. E., Skorzynska, K. E., Dagnaes-Hansen, F., Plesner, T. L., Hauge, E. M., Plesner, T., & Delaisse, J.-M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080627 · Cited by 325
“They may initially promote differentiation of these pre-OCs through RANKL expression, and be programmed later to become boneforming cells.(39,40) OB progenitors may also originate from more remote sites because they were reported in the circulation of patients showing enhanced bone formation.”
BackgroundModel structure and control of bone remodeling: A theoretical study
Pivonka, P., Zimak, J., Smith, D. W., Gardiner, B. S., Dunstan, C. R., Sims, N. A., John Martin, T., & Mundy, G. R. (2008) · Bone · doi:10.1016/j.bone.2008.03.025 · Cited by 298
Metadata
- Authors
- Gori, F.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-12-01
- Volume
- 141
- Issue
- 12
- Pages
- 4768-4776
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W4245062444
- Cited by
- 73
- References
- 0
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated. https://app.cochat.ai/papers/10.1210/en.141.12.4768
- The paper
- Gori, F. (2000). The Expression of Osteoprotegerin and RANK Ligand and the Support of Osteoclast Formation by Stromal-Osteoblast Lineage Cells Is Developmentally Regulated. Endocrinology. https://doi.org/10.1210/en.141.12.4768
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.